Investing Research

By Andrew Nyquist Over the past few days, the S&P 500 has been able to pierce 1257 briefly, only to close at or below the level.  So why...

By Joshua Schroeder High-Tech Pharmacal (HITK) is a small cap biotech/pharmaceutical stock that I added to my portfolio in July and August and then recommended on...

I'm running on market fumes...  Over the weekend I saw the futures jump higher and spent much of the past day and a half trying...

By Andrew Nyquist It's been a long couple of weeks for the stock market.  After breaking down and out of the pennant formation, the S&P 500...

The good news is that the timing for this piece couldn't be better, for when markets start to creep with volatility, emotion, and uncertainty,...

By Andrew Nyquist The markets have melted down since breaking the bottom edge of the flag / pennant formation.  Overnight futures indicated a rough start to the week,...

By Andrew Nyquist Once again, I want to thank the many readers that take the time to send in comments and questions each week.  As most...

By Andrew Nyquist So the saying goes, "the tension on the tape" is thick.  Evidence of this lies in the aforementioned multi-week pennant formation on the S&P 500. ...

By Andrew Nyquist There are many different technical patterns that can and do form in stocks and market indices throughout the course of time.  Some are...

By Andrew Nyquist After a fast and furious run of higher prices in June and July, Gold topped out and fell 20 percent, prompting many analysts...